The immune organoid was created in the lab of Ankur Singh, assistant professor of mechanical and aerospace engineering, who applies engineering principles to the study and manipulation of the human immune system. The work was published online June 3 in Biomaterials and will appear later in print.
The synthetic organ is bio-inspired by secondary immune organs like the lymph node or spleen. It is made from gelatin-based biomaterials reinforced with nanoparticles and seeded with cells, and it mimics the anatomical microenvironment of lymphoid tissue. Like a real organ, the organoid converts B cells – which make antibodies that respond to infectious invaders – into germinal centers, which are clusters of B cells that activate, mature and mutate their antibody genes when the body is under attack. Germinal centers are a sign of infection and are not present in healthy immune organs.
The engineers have demonstrated how they can control this immune response in the organ and tune how quickly the B cells proliferate, get activated and change their antibody types. According to their paper, their 3-D organ outperforms existing 2-D cultures and can produce activated B cells up to 100 times faster.
The immune organ, made of a hydrogel, is a soft, nanocomposite biomaterial. The engineers reinforced the material with silicate nanoparticles to keep the structure from melting at the physiologically relevant temperature of 98.6 degrees.
The organ could lead to increased understanding of B cell functions, an area of study that typically relies on animal models to observe how the cells develop and mature.
What’s more, Singh said, the organ could be used to study specific infections and how the body produces antibodies to fight those infections – from Ebola to HIV.
“You can use our system to force the production of immunotherapeutics at much faster rates,” he said. Such a system also could be used to test toxic chemicals and environmental factors that contribute to infections or organ malfunctions.
Read more: Engineers’ synthetic immune organ produces antibodies
The Latest on: Immune therapies
[google_news title=”” keyword=”Immune therapies” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Immune therapies
- AC Immune Reports First Quarter 2024 Financial Results and Provides a Corporate Updateon May 13, 2024 at 4:16 am
AC Immune Reports First Quarter 2024 Financial Results and Provides a Corporate UpdateLandmark deal announced with Takeda for ACI-24.060 with ...
- AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer’s Diseaseon May 13, 2024 at 4:07 am
AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer’s DiseaseTakeda to ...
- Takeda pays AC Immune $100M upfront for Alzheimer's drug as phase 2 readout nearson May 12, 2024 at 10:51 pm
Back in January 2023, AC Immune reported that ACI-24.060 elicited an anti-Abeta antibody response as early as Week 6, meaning the therapy may help prevent or clear plaques in the brain thought to ...
- Breakthrough therapies are saving lives. Can we afford them?on May 12, 2024 at 3:32 pm
Harnessing the body’s own cells to fight disease, long a medical dream, is finally a reality. Now comes the bill. Last month, Stanford became the first hospital in the nation to use a new $515,000 ...
- Breakthrough therapies at Stanford are saving lives. Can we afford them?on May 11, 2024 at 10:45 pm
Stanford cell therapy technologist Thomas Orozco thaws the treated immune cells from a patient with advanced melanoma. The cells are collected from the patient’s tumor and fortified in a laboratory to ...
- Cancer Vaccine Triggers Fierce Immune Response to Fight Malignant Brain Tumors in Human Patientson May 11, 2024 at 6:37 am
In the first human trial, an mRNA cancer vaccine at the University of Florida triggered immune systems to fiercely attack glioblastoma.
- Direct measurement of the interaction between immune cells and cancer cells from a patient's biopsyon May 10, 2024 at 10:24 am
Researchers have unveiled a technology that promises to improve cancer treatment decisions based on a patient's biopsy. The pioneering biological research and development measures changes in immune ...
- EU researchers are taking fresh approaches to understanding immune-system disorders for more effective treatmentson May 10, 2024 at 10:09 am
In mid-2015 and early 2016 in Finland, a group of scientists became interested in inspecting doormats. The pursuit, while seemingly unusual, had a serious aim: to determine whether a higher mix of ...
- Breakthrough research offers promise for developing new immune therapies for canceron May 9, 2024 at 10:34 pm
Scientists from Trinity College Dublin have made an important breakthrough that offers promise for developing new immune therapies for cancer.
- Supercharging immune cells to battle blood cancer: Advances in cancer immunotherapyon May 9, 2024 at 6:51 am
Cancer has a profound impact on human life, and immune checkpoint therapy (ICT) has made remarkable strides in cancer treatment. However, ICT faces challenges such as low overall response rates and ...
via Bing News